B Roca, M Roca - Cleveland Clinic journal of medicine, 2015 - pubmed.ncbi.nlm.nih.gov
Dabigatran (a direct thrombin inhibitor) and rivaroxaban, apixaban, and edoxaban (direct
activated factor X inhibitors) are increasingly being used in clinical practice. Compared with …